Latest Press Releases
View all
TimeHeadline
Just nowSFG Quarterly Activities/Appendix 4CCash Flow Report
Just nowBSA Announces On-Market Share Buy-Back
Just nowPlacement
Just nowQ3 FY26 Activities Report and Appendix 4C
Just nowFY26 Q1 Quarterly Activities Report and Appendix 4C
Tscan Therapeutics Inc logo

Tscan Therapeutics Inc

About

Tscan Therapeutics Inc (NASDAQ:TCRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 27 2026
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
Apr 8 2026
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 4 2026
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 26 2026
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
Feb 25 2026
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Financials

Revenue
$10.32 M
Market Cap
$57.47 M
EPS
-1.00

Community Chat

Ask AI

6ix6ix